Amprius Technologies, Inc.
For the period ended Jun 30, 2025. Filed Aug 7, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 30, 2025 · Filed Aug 7, 2025
AMPX$9.17-3.7%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Stockholders’ Equity
| Common Stock · AdditionalPaid-inCapital · AccumulatedOther Comprehensive Loss · AccumulatedDeficit · TotalStockholders’Equity | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| (In thousands, except share data) · Shares · Amount | ||||||||||||
| Balance as of December 31, 2024 | 116,934,314 | $12 | $243,794 | $— | $(174,334) | $69,472 | ||||||
| Issuance of common stock in connection with the At Market Issuance Sales Agreement, net of issuance cost | 2,585,646 | — | 8,429 | — | — | 8,429 | ||||||
| Issuance of common stock upon exercise of stock options and vesting of restricted stock units | 1,026,117 | — | 48 | — | — | 48 | ||||||
| Stock-based compensation | — | — | 1,822 | — | — | 1,822 | ||||||
| Net loss | — | — | — | — | (9,371) | (9,371) | ||||||
| Other comprehensive loss | — | — | — | (4) | — | (4) | ||||||
| Balance as of March 31, 2025 | 120,546,077 | $12 | $254,093 | $(4) | $(183,705) | $70,396 | ||||||
| Issuance of common stock in connection with the At Market Issuance Sales Agreement, net of issuance cost | 3,175,850 | 1 | 9,706 | — | — | 9,707 | ||||||
| Issuance of common stock upon exercise of stock options and vesting of restricted stock units | 1,353,910 | — | 1,018 | — | — | 1,018 | ||||||
| Stock-based compensation | — | — | 1,906 | — | — | 1,906 | ||||||
| Net loss | — | — | — | — | (6,370) | (6,370) | ||||||
| Other comprehensive loss | — | — | — | $(3) | — | (3) | ||||||
| Balance as of June 30, 2025 | 125,075,837 | $13 | $266,723 | $(7) | $(190,075) | $76,654 | ||||||
| Common Stock · AdditionalPaid-inCapital · AccumulatedOther Comprehensive Loss · AccumulatedDeficit · TotalStockholders’Equity | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| (In thousands, except share data) · Shares · Amount | |||||||||||
| Balance as of December 31, 2023 | 88,869,463 | $9 | $189,454 | $— | $(129,663) | $59,800 | |||||
| Issuance of common stock in connection with the At Market Issuance Sales Agreement, net of issuance cost | 2,853,266 | — | 8,746 | — | — | 8,746 | |||||
| Issuance of common stock upon exercise of stock options and vesting of restricted stock units | 551,436 | — | 28 | — | — | 28 | |||||
| Stock-based compensation | — | — | 1,247 | — | — | 1,247 | |||||
| Net loss | — | — | — | — | (9,886) | (9,886) | |||||
| Balance as of March 31, 2024 | 92,274,165 | $9 | $199,475 | — | $(139,549) | $59,935 | |||||
| Issuance of common stock in connection with the At Market Issuance Sales Agreement, net of issuance cost | 1,043,053 | — | 2,074 | — | — | 2,074 | |||||
| Issuance of common stock upon exercise of stock warrants, net of issuance cost | 13,075,664 | 2 | 13,626 | — | — | 13,628 | |||||
| Issuance of common stock upon exercise of stock options and vesting of restricted stock units | 1,585,405 | — | 68 | — | — | 68 | |||||
| Stock-based compensation | — | — | 1,941 | — | — | 1,941 | |||||
| Net loss | — | — | — | — | (12,517) | (12,517) | |||||
| Balance as of June 30, 2024 | 107,978,287 | $11 | $217,184 | $— | $(152,066) | $65,129 | |||||
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.